Montana Zantac lawyers claim digestive cancer lawsuit settlement.
Montana Zantac Lawyers for Cancer Claims
Billings · Missoula · Great Falls · Bozeman
Call Now: (888) 510-9256
Hotline Open 24 Hours
Time is Running Out!
Our Montana Zantac lawyers represent antacid patients diagnosed with certain cancers. Montana Zantac lawsuits claim the drug manufacturer Sanofi failed to warn of risks of digestive cancer.
As such, Montana Zantac patients diagnosed with specific cancers may be eligible to claim a cash settlement.
- Stomach / Gastric Cancer
- Bladder Cancer
- Pancreatic Cancer
- Esophageal Cancer
- Liver Cancer
- Kidney Cancer
- Lung Cancer
- Breast Cancer
- Colon Cancer
- Rectal Cancer
- Prostate Cancer
Our team of attorneys have represented thousands of victims of dangerous pharmaceutical drugs. In doing so, we have recovered millions of dollars in settlement funds on their behalf.
However, we only pursue Zantac compensation from the drug manufacturers and their affiliates, and do not file claims against our clients’ doctors or hospitals.
No Legal Fee Unless You Obtain a Settlement
While compensation may be available to qualified Zantac claimants, victims are urged to act promptly. The #1 claim Montana Zantac victims can make for cancer compensation is one that is filed within the Statute of Limitations time period. Click here for the latest information on the Zantac multi-district litigation.
Our Montana Zantac cancer lawyers are available to review claims now. We offer a free case evaluation to confirm usage of Zantac and diagnosis of a qualified cancer. Further, we never charge a legal fee unless a financial recovery is obtained for our client.
Contact our Montana Zantac lawyers today.
Montana Zantac Lawsuits to Claim Cancer Settlement
Montana Zantac lawyers have steered a significant legal battle involving Zantac (ranitidine), a popular over-the-counter and prescription medication used to treat heartburn and other gastrointestinal conditions.
Montana Zantac lawsuits allege long-term use is linked to a variety of digestive cancers. Class action style lawsuits claim Zantac manufacturer Sanofi failed to warn patients about these associated risks. Accordingly, the courts have seen a surge in settlement claims filed by MT Zantac patients diagnosed with such cancers.
Montana Zantac Cancer Lawyer Cites Scientific Research & Reports
The controversy surrounding Zantac primarily revolves around the presence of N-Nitrosodimethylamine (NDMA), a probable human carcinogen. Montana Zantac stomach cancer lawyers cite studies indicating that NDMA can form from ranitidine under certain conditions, including during the digestive process. The levels of NDMA found in some ranitidine products have raised significant concerns, as prolonged exposure to high levels of this compound has been linked to an increased risk of gastric cancer and other digestive tract cancers.
Valisure’s 2019 Testing Connects Zantac Use to Esophageal Cancer
Montana Zantac esophageal cancer lawsuits rely on a 2019 study conducted by the online pharmacy Valisure. The comprehensive testing performed by Valisure on various ranitidine products delivered alarming results. Valisure detected extremely high levels of NDMA in every ranitidine product tested, including Zantac, far exceeding the FDA’s acceptable daily intake. They immediately alerted the FDA and requested a recall of ranitidine products. Valisure’s report started a wave of settlement claims across Montana by lawyers seeking compensation for esophageal cancer, bladder cancer, and more.
FDA’s Statement on NDMA Liver Cancer & Action on Zantac
Following Valisure’s report, the U.S. Food and Drug Administration (FDA) conducted its own investigation. In April 2020, the FDA announced that it found unacceptable levels of NDMA in several ranitidine products and requested the immediate removal of these products from the market. Montana Zantac liver cancer lawyers claim these elevated NDMA levels explain antacid patients’ illness. Further, the FDA’s report underscores numerous other potential health risks associated with long-term exposure to NDMA. Click here to view the FDA removal warning.
Sloan Kettering Study Links Zantac to Bladder & Stomach Cancer
Researchers at the Memorial Sloan Kettering Cancer Center conducted a study published in 2020, examining the link between ranitidine use and cancer. They found a statistically significant association between prolonged ranitidine use and an increased risk of bladder and stomach cancers. This study provided compelling evidence for Montana Zantac bladder & stomach cancer lawsuits as to the potential carcinogenic effects of ranitidine when used over a long period.
International Agency for Research on Cancer (IARC) Classifies Pancreatic Cancer
The International Agency for Research on Cancer, part of the World Health Organization, classified NDMA as a probable human carcinogen based on studies that showed an increased risk of cancer in animals exposed to NDMA. Montana Zantac pancreatic cancer lawyers claim this research supports lawsuit settlements. The IARC’s classification has added to the concerns about ranitidine’s safety globally, given the high levels of NDMA found in Zantac.
Regulatory Response in Montana Supports Zantac Cancer Victims
The findings from these major studies and reports have led to a significant reevaluation of Zantac’s safety, culminating in its removal from the market. Patients who have used Zantac for extended periods should consult with healthcare providers to discuss alternative treatments and assess any potential health risks. If a cancer diagnosis is received, antacid patients can consult with a Montana Zantac lawyer about filing a settlement claim.
MT Zantac Cancer Lawsuit Allegations
The legal claims against Zantac manufacturers focus on several key allegations:
- Failure to Warn: Montana Zantac plaintiffs claim that the manufacturers knew or should have known about the risk of NDMA formation and its carcinogenic potential but failed to adequately warn consumers and healthcare providers.
- Negligence in Manufacturing: Some Montana Zantac lawsuits claim that the process used to manufacture ranitidine resulted in the formation of NDMA and cancer, accusing the manufacturers of negligence for not using safer alternatives.
- Misrepresentation of Safety: Montana Zantac lawyers also claim that the manufacturers misrepresented the drug’s safety, marketing it as a safe medication without disclosing the risks of NDMA-associated cancer.
Types of Cancer Linked to Zantac
Montana lawsuits have brought attention to the potential link between Zantac and several types of cancer:
- Gastric Cancer: Given ranitidine’s use in treating stomach conditions, the alleged link to stomach cancer is particularly concerning. MT lawyers argue that the NDMA in Zantac can cause mutations leading to gastric cancer.
- Esophageal Cancer: Esophageal cancer claims focus on the proximity of the esophagus to the stomach, suggesting that exposure to NDMA from ranitidine could increase the risk of cancer in this area.
- Liver Cancer: The liver’s role in metabolizing substances can make it vulnerable to carcinogens like NDMA, leading to MT lawsuit claims that Zantac use is linked to an increased risk of liver cancer.
- Bladder Cancer: NDMA is excreted through the urine, raising concerns that it could cause bladder cancer in individuals using Zantac.
- Pancreatic Cancer: Pancreatic cancer is also claimed by MT plaintiffs alleging that NDMA exposure from Zantac use could contribute to its development.
Additional Cancers Linked to Zantac
- Lung Cancer
- Breast Cancer
- Kidney Cancer
- Colorectal Cancer
- Prostate Cancer
Time is Running Out!
Call our Montana Zantac settlement lawyers now!
Call Now: (888) 510-9256
We file Zantac cancer lawsuits in the State of Montana and across the United States.
- Billings, MT
- Missoula, MT
- Great Falls, MT
- Bozeman, MT
- Butte-Silver Bow, MT
- Helena, MT
- Kalispell, MT
Contact our Montana Zantac lawyers today for a free case review.